Invasive Cardiovascular Monitors  When I use them

     
       

 

         
       

I use PACs when I am dealing with a patient who is hypotensive / shocked, and I cannot rely on right atrial pressure as a guide to LV preload. Examples of this are refractory cardiogenic shock, myocardial contusion, myocardial ischemia complicating septic shock, or sepsis in a patient with previous myocardial disease. On occasion it is necessary to perform right heart catheterization in a patient who is not responding to conventional therapy.

The oximetric (continuous cardiac output) pulmonary artery catheter has been advocated as a useful guide to early aggressive resuscitation, particulary in trauma. The stroke volume, CVP and PCWP and mixed venous oxygen saturation are used to guide fluid resuscitation. Although none of these are hard endpoints of resuscitation, the logic of this approach is that it prevents under and over-resuscitation, particularly when large amounts of volume are being given. The counter argument is that patients are rarely over-resuscitated, and non invasive monitors such as the esophageal doppler may provide more rapid (and less hazardous) measurement of stroke volume.

You will undoubtedly work with physicians who believe that PACs are the bedrock of critical care, and others that they are a faddish cult (Robin 1985). Much of the information derived from PACs cannot be predicted by clinical examination (Connors 1983). I believe that they have greatly helped our understanding of  cardiovascular physiology in critical illness, so much so that, in many cases, particularly in sepsis, we can now predict PAC findings without catheterizing the right heart.

What follows is thirteen tips for using invasive pressure monitors:

  1. There is no “normal” CVP or wedge pressures: you must follow a trend and look at responses to therapy, principally fluid boluses.

  2. Abnormal hearts – those with acutely ischemic ventricles, fibrotic or contused myocardiums, are less compliant, and require higher filling pressures to project a “normal” stroke volume. They progressively dilate until there is sufficient muscle stretch to eject this volume. This is why the ejection fraction progressively falls.

  3. It is preferable to use stroke volume rather than cardiac output as the measured response to therapy, as the latter is influence by heart rate, which may be fast for a variety of reasons, and mask a poorly performing ventricle (in sepsis the cardiac output is characteristically high and the stroke volume low).

  4. A low mixed venous oxygen saturation (SvO2) is usually an indication of under-resuscitation, and volume loading is required. It is worthwhile to match this process withlactic acid concentration. An increased SvO2 is difficult to interpret: it may indicate inability to extract oxygen, it may indicate a hyperdynamic circulation.

  5. Normal hearts have huge physiologic reserve, and can cope very well with high filling volumes, consequently, you should never go wrong with aggressively volume loading shocked patients: you will adequately fill abnormal hearts without injuring normal hearts. Always aim your CVP and PCWP targets high!

  6. The first treatment for all kinds of shock, including cardiogenic, is volume, volume and more volume.

  7. A little extravascular lung water is probably less harmful than vasoactive drugs: do not skimp on the fluids for fear of flooding the lungs.

  8. There is no magic mathematical formula which allows you to figure out the influence of PEEP on PCWP and CVP: if transalveolar pressure is kept constant, the trend should be consistent.

  9. The pulmonary artery catheter is a monitor not a therapy: it is not a surrogate for resuscitative therapy or source control.

  10. During the resuscitative process, it should rapidly become apparent to you the CVP and PCWP that the patient’s heart “likes” (in terms of stroke volume and CVP). This is important with regard to fluid mobilization (“deresuscitation”) and redistribution.

  11. If the patient’s blood pressure or stroke volume begins to fall and the filling pressures are higher than those at which optimal stroke volume/cardiac output was obtained, then the patient has likely mobilized fluid, and is now “overloaded”: preload reducing agents such as nitrates and diuretics are required.

  12. An evolving increase in the stroke volume likewise represents hypervolemia: the patient will autodiurese if the kidneys are functioning normally.

  13. Be cautious with the use of derived variables from pulmonary artery catheters. I speak in particular of the “systemic vascular resistance” (SVR). There is, unquestionably, and abnormality in peripheral resistance (PR) in all forms of distributive shock, and appropriate vasoconstriction (and thus high PR) in hypovolemic and cardiogenic shock. Unfortunately, there is no easy method for measuring PR. The SVR is calculated from the equation for change in pressure/flow, which is MAP-CVP/CO. The problem with this equation is the pulsatility of cardiac output flow – it is determined by the heart rate. A fast heart rate for the same stroke volume will lead to the measurement of a lower SVR than before. The PR may not have changed.

         
                   
       

         
     

       
       

Please note: these tutorials are for personal study purposes only.  They are not currently peer reviewed, and no responsibility will be taken for mistakes or inaccuracies. Reproduction of information is forbidden. All material is copyrighted by the GasWorks Group.